Tocqueville Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-49,742
Closed -$1.39M 568
2022
Q4
$1.39M Sell
49,742
-55,159
-53% -$1.41M 0.03% 334
2022
Q3
$2.46M Sell
104,901
-5,636
-5% -$170K 0.05% 255
2022
Q2
$3.73M Sell
110,537
-4,561
-4% -$160K 0.07% 246
2022
Q1
$4.02M Buy
115,098
+11,847
+11% +$405K 0.06% 262
2021
Q4
$3.14M Sell
103,251
-71,694
-41% -$2.34M 0.04% 323
2021
Q3
$5.74M Sell
174,945
-15,128
-8% -$484K 0.09% 226
2021
Q2
$5.75M Buy
+190,073
New +$6.26M 0.08% 236

Other funds holding OGN

Tocqueville Asset Management's OGN Position: Q1 2023 in Review

Tocqueville Asset Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 49,742 shares — an estimated $1.39M sold.

Tocqueville Asset Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $5.75M in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Tocqueville Asset Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Tocqueville Asset Management sold 49,742 Organon & Co shares in Q1 2023, an estimated $1.39M.
  • Tocqueville Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Tocqueville Asset Management's Organon & Co position peaked at $5.75M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Tocqueville Asset Management's 13F filing for Q1 2023, filed 10 May 2023.